Stabilization of p53 and transactivation of its target genes in response to replication blockade

被引:0
|
作者
Bijaya K Nayak
Gokul M Das
机构
[1] Molecular Oncology Research Program,Department of Surgery
[2] University of Texas Health Science Center,Department of Pharmacology & Therapeutics
[3] Roswell Park Cancer Institute,undefined
来源
Oncogene | 2002年 / 21卷
关键词
p53; transactivation; p21; replication blockade; hydroxyurea; aphidicolin;
D O I
暂无
中图分类号
学科分类号
摘要
Although it is clear that p53 plays a pivotal role in G1/G2 checkpoints to conserve genomic integrity, its role in S phase checkpoint is less well understood. Recently, it has been reported that p53 is transcriptionally impaired even though it is stabilized during replication blockade. However, the mechanisms underlying this phenomenon are not known. In the present study, it has been shown that p53 accumulates and transactivates its target genes such as p21, gadd45 and bax in response to replication blockade in normal and cancer cells. Lack of transcriptional activation under similar conditions in cells lacking p53 shows that p53-target gene activation during replication blockade is indeed p53-dependent. Further, transactivation of p21 in response to replication blockade by hydroxyurea and aphidicolin is similar to that in response to ionizing radiation except that the latter is more immediate compared to the response to replication blockade. These findings suggest that impairment of transcriptionally active p53 in response to replication blockade is not a general phenomenon.
引用
收藏
页码:7226 / 7229
页数:3
相关论文
共 50 条
  • [31] p53 and its target genes are essential for chemotherapy-induced hair loss
    Botchkarev, V
    Komarova, E
    Siebenhaar, F
    Botchkareva, N
    Sharov, A
    Komarov, P
    Maurer, M
    Gudkov, A
    Gilchrest, B
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 428 - 428
  • [32] Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains
    Venot, C
    Maratrat, M
    Sierra, V
    Conseiller, E
    Debussche, L
    [J]. ONCOGENE, 1999, 18 (14) : 2405 - 2410
  • [33] Definition of a p53 transactivation function-deficient mutant and characterization of two independent p53 transactivation subdomains
    Corinne Venot
    Michel Maratrat
    Véronique Sierra
    Emmanuel Conseiller
    Laurent Debussche
    [J]. Oncogene, 1999, 18 : 2405 - 2410
  • [34] TRANSACTIVATION OF P53 IN P53 MUTANT-CELL LINES IN-VIVO
    PARK, DJ
    NAKAMURA, H
    CHUMAKOV, AM
    SAID, JW
    MILLER, CW
    CHEN, DL
    KOEFFLER, HP
    [J]. BLOOD, 1993, 82 (10) : A39 - A39
  • [35] Regression based predictor for p53 transactivation
    Sivakumar Gowrisankar
    Anil G Jegga
    [J]. BMC Bioinformatics, 10
  • [36] Regression based predictor for p53 transactivation
    Gowrisankar, Sivakumar
    Jegga, Anil G.
    [J]. BMC BIOINFORMATICS, 2009, 10 : 215
  • [37] Identifying p53 Target Genes Using Hypomorphic Variants
    Bhatta, Bibek
    Cooks, Tomer
    [J]. CANCER DISCOVERY, 2023, 13 (07) : 1518 - 1520
  • [38] In search of p53 target genes for the therapeutic manipulation of cancer
    Liu, SX
    Seidel-Dugan, C
    [J]. CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2006, 9 (02) : 176 - 183
  • [39] NuMA Is Required for the Selective Induction of p53 Target Genes
    Ohata, Hirokazu
    Miyazaki, Makoto
    Otomo, Ryo
    Matsushima-Hibiya, Yuko
    Otsubo, Chihiro
    Nagase, Takahiro
    Arakawa, Hirofumi
    Yokota, Jun
    Nakagama, Hitoshi
    Taya, Yoichi
    Enari, Masato
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2013, 33 (12) : 2447 - 2457
  • [40] A small molecule directly inhibits the p53 transactivation domain from binding to replication protein A
    Glanzer, Jason G.
    Carnes, Katie A.
    Soto, Patricia
    Liu, Shengqin
    Parkhurst, Lawrence J.
    Oakley, Gregory G.
    [J]. NUCLEIC ACIDS RESEARCH, 2013, 41 (03) : 2047 - 2059